Paper25616355
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
Engels CC and 12 others. Breast Cancer Res Treat, 2015. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis. Papers, record 25616355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25616355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Immunophenotyping | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Androstadienes | |
| Chemotherapy, Adjuvant | |
| Combined Modality Therapy | |
| Female | |
| Forkhead Transcription Factors | |
| HLA-G Antigens | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Middle Aged | |
| Postmenopause | |
| Prognosis | |
| Receptors, Estrogen | |
| Tamoxifen | |
| HLA-E Antigens |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24649219 | FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis. | Mol Clin Oncol | 2013 | https://conductscience.org/library/papers/24649219 | PubMed |
| 2 | 12407407 | Natural selection of tumor variants in the generation of "tumor escape" phenotypes. | Nat Immunol | 2002 | https://conductscience.org/library/papers/12407407 | PubMed |
| 3 | 21087898 | Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/21087898 | PubMed |
| 4 | 19188178 | Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19188178 | PubMed |
| 5 | 20145162 | The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20145162 | PubMed |
| 6 | 21483002 | Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21483002 | PubMed |
| 7 | 11823860 | Gene expression profiling predicts clinical outcome of breast cancer. | Nature | 2002 | https://conductscience.org/library/papers/11823860 | PubMed |
| 8 | 22301780 | Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. | Mol Endocrinol | 2012 | https://conductscience.org/library/papers/22301780 | PubMed |
| 9 | 15761078 | Global cancer statistics, 2002. | CA Cancer J Clin | 2005 | https://conductscience.org/library/papers/15761078 | PubMed |
| 10 | 24213679 | Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? | Cancer Immunol Immunother | 2014 | https://conductscience.org/library/papers/24213679 | PubMed |
| 11 | 22465232 | What are regulatory T cells (Treg) regulating in cancer and why? | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22465232 | PubMed |
| 12 | 17445213 | HLA expression and cancer--14th IHIWS immunohistochemistry quality control exercise exchange results. | Tissue Antigens | 2007 | https://conductscience.org/library/papers/17445213 | PubMed |
| 13 | 8175547 | Adenosine, an endogenous anti-inflammatory agent. | J Appl Physiol (1985) | 1994 | https://conductscience.org/library/papers/8175547 | PubMed |
| 14 | 12618909 | Analysis of HLA-E expression in human tumors. | Immunogenetics | 2003 | https://conductscience.org/library/papers/12618909 | PubMed |
| 15 | 17008531 | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. | Science | 2006 | https://conductscience.org/library/papers/17008531 | PubMed |
| 16 | 21717105 | CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/21717105 | PubMed |
| 17 | 9886828 | Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. | Endocrinology | 1999 | https://conductscience.org/library/papers/9886828 | PubMed |
| 18 | 16720680 | Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16720680 | PubMed |
| 19 | 16382061 | A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16382061 | PubMed |
| 20 | 23280127 | Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients. | Int J Biol Markers | 2012 | https://conductscience.org/library/papers/23280127 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41732488 | Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer. | iScience | 2026 | https://conductscience.org/library/papers/41732488 | PubMed |
| 41599141 | Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41599141 | PubMed |
| 38672117 | Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672117 | PubMed |
| 38310272 | Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects. | J Transl Med | 2024 | https://conductscience.org/library/papers/38310272 | PubMed |
| 37060036 | Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial. | Breast Cancer Res | 2023 | https://conductscience.org/library/papers/37060036 | PubMed |
| 36692642 | The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis. | Clin Transl Oncol | 2023 | https://conductscience.org/library/papers/36692642 | PubMed |
| 36119489 | Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36119489 | PubMed |
| 36046791 | Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36046791 | PubMed |
| 34361031 | A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34361031 | PubMed |
| 34276691 | HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges. | Front Immunol | 2021 | https://conductscience.org/library/papers/34276691 | PubMed |
| 34180352 | Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer. | Bioengineered | 2021 | https://conductscience.org/library/papers/34180352 | PubMed |
| 33435254 | Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33435254 | PubMed |
| 32106121 | Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1. | Chin Med J (Engl) | 2020 | https://conductscience.org/library/papers/32106121 | PubMed |
| 31829264 | Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/31829264 | PubMed |
| 31391067 | Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/31391067 | PubMed |
| 30319626 | Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges. | Front Immunol | 2018 | https://conductscience.org/library/papers/30319626 | PubMed |
| 30172273 | [Study Progression on Non-small Cell Lung Cancer with EGFR Mutation Treated by Immune Checkpoint Inhibitors]. | Zhongguo Fei Ai Za Zhi | 2018 | https://conductscience.org/library/papers/30172273 | PubMed |
| 29983594 | A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29983594 | PubMed |
| 29780664 | A New Paradigm for Tissue Diagnostics: Tools and Techniques to Standardize Tissue Collection, Transport, and Fixation. | Curr Pathobiol Rep | 2018 | https://conductscience.org/library/papers/29780664 | PubMed |
| 29187886 | Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis. | J Cancer | 2017 | https://conductscience.org/library/papers/29187886 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25616355
GET https://conductscience.org/api/papers/v1/25616355/references?page=2